← back to search

Christopher Y. Park

University of Michigan · US
Area of research
Hematology · Molecular Biology
Research interest
Research interests include Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, MicroRNA in disease regulation, and RNA Research and Splicing.
h-index
51
citations
15,768
works
208
NIH funding
primary concept
email

Recent publications

Kitlo hematopoietic stem cells exhibit distinct lymphoid-primed chromatin landscapes that enhance thymic reconstitution
Nature Communications 2025cited by 5position: middledoi
Engineering antibody–drug conjugates targeting an adhesion GPCR, CD97
Proceedings of the National Academy of Sciences 2025cited by 1position: middledoi
Mapping the landscape of histomorphological cancer phenotypes using self-supervised learning on unannotated pathology slides
Nature Communications 2024cited by 57position: middledoi
The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerability
Cell Reports 2023cited by 26position: middledoi
Data from Therapeutic Antibody Targeting of CD47 Eliminates Human Acute Lymphoblastic Leukemia
2023cited by 0position: middledoi
Pathogenic Mechanisms in Acute Myeloid Leukemia
Current Treatment Options in Oncology 2022cited by 31position: lastdoi
Chronic activation of endothelial MAPK disrupts hematopoiesis via NFKB dependent inflammatory stress reversible by SCGF
Nature Communications 2020cited by 78position: middledoi
Hematopoietic Stem and Progenitor Cells Exhibit Stage-Specific Translational Programs via mTOR- and CDK1-Dependent Mechanisms
Cell stem cell 2020cited by 40position: lastdoi
Whole-genome deep-learning analysis identifies contribution of noncoding mutations to autism risk
Nature Genetics 2019cited by 327position: middledoi
FMRP has a cell-type-specific role in CA1 pyramidal neurons to regulate autism-related transcripts and circadian memory
eLife 2019cited by 120position: middledoi
Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice
Blood 2019cited by 73position: middledoi
CD97 is a critical regulator of acute myeloid leukemia stem cell function
The Journal of Experimental Medicine 2019cited by 42position: lastdoi
AGO CLIP Reveals an Activated Network for Acute Regulation of Brain Glutamate Homeostasis in Ischemic Stroke
Cell Reports 2019cited by 28position: middledoi
ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity
eLife 2018cited by 160position: middledoi
Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression
Cell 2017cited by 698position: middledoi
CD99 is a therapeutic target on disease stem cells in myeloid malignancies
Science Translational Medicine 2017cited by 160position: lastdoi
Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells
Blood 2017cited by 130position: middledoi
cTag-PAPERCLIP Reveals Alternative Polyadenylation Promotes Cell-Type Specific Protein Diversity and Shifts Araf Isoforms with Microglia Activation
Neuron 2017cited by 75position: middledoi
<i>miR-99</i> regulates normal and malignant hematopoietic stem cell self-renewal
The Journal of Experimental Medicine 2017cited by 57position: lastdoi
Aging, hematopoiesis, and the myelodysplastic syndromes
Blood Advances 2017cited by 50position: lastdoi
Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia
Nature Medicine 2016cited by 399position: middledoi
Regulatory consequences of neuronal ELAV-like protein binding to coding and non-coding RNAs in human brain
eLife 2016cited by 148position: middledoi
NOVA2-mediated RNA regulation is required for axonal pathfinding during development
eLife 2016cited by 130position: middledoi
Molecular mechanisms underlying lineage bias in aging hematopoiesis
Seminars in Hematology 2016cited by 84position: lastdoi
miRNA–target chimeras reveal miRNA 3′-end pairing as a major determinant of Argonaute target specificity
Nature Communications 2015cited by 341position: middledoi
Mesoscale Nanoparticles Selectively Target the Renal Proximal Tubule Epithelium
Nano Letters 2015cited by 174position: middledoi
miR-29a maintains mouse hematopoietic stem cell self-renewal by regulating Dnmt3a
Blood 2015cited by 83position: lastdoi
Author response: Regulatory consequences of neuronal ELAV-like protein binding to coding and non-coding RNAs in human brain
2015cited by 1position: middledoi
Hematopoietic Stem Cell Origin of <i>BRAF</i> V600E Mutations in Hairy Cell Leukemia
Science Translational Medicine 2014cited by 126position: middledoi
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo
The Journal of Experimental Medicine 2013cited by 321position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

John J. Fak · Rockefeller University9 papers (2015–2019)Robert B. Darnell · Rockefeller University9 papers (2015–2019)Wenhuo Hu · Neurological Surgery6 papers (2013–2019)Stephen S. Chung · Southwestern Medical Center5 papers (2014–2019)Omar Abdel‐Wahab · Presbyterian Hospital5 papers (2012–2017)Ilana Zucker-Scharff · Howard Hughes Medical Institute4 papers (2015–2018)Iannis Aifantis · NYU Langone Health4 papers (2012–2017)Ross L. Levine · Leukemia and Lymphoma Society4 papers (2012–2017) · 3 papers (2017–2020)Michael J. Moore · Regeneron (United States)3 papers (2015–2019)Delphine Ndiaye‐Lobry · Centre National de la Recherche Scientifique3 papers (2012–2017)Harold K. Elias · National Institutes of Health Clinical Center3 papers (2016–2025)Luisa Cimmino · University of Miami3 papers (2013–2017)Ari Melnick · Cornell University3 papers (2012–2017)Gaëlle Martin · New York University3 papers (2017–2020)Young Rock Chung · New York University3 papers (2012–2014)Claudia Scheckel · University of Zurich3 papers (2015–2019)Elodie Drapeau · Icahn School of Medicine at Mount Sinai2 papers (2015–2016)Aristotelis Tsirigos · NYU Langone Health2 papers (2017–2024)Xinyang Zhao · Zunyi Medical University2 papers (2012–2012)